Assessment of subclinical atherosclerosis to improve prevention of coronary artery disease

为了预防心脏病，我们目前根据病人的危险因素给他们使用他汀类药物。通过结合识别症状前疾病的测试（如其他筛查项目）来改进风险预测，可以更好地识别那些最有可能从他汀类药物中受益的人，并节省医疗成本。本研究旨在确定这种筛查策略是否具有成本效益，并保证改变目前澳大利亚冠心病一级预防的方法。

To prevent heart disease, we currently treat many patients with statins based on their risk factors. Improving risk prediction by combining tests that identify pre-symptomatic disease (like other screening programs) can better identify those most likely to benefit from statins and save healthcare costs. This study aims to determine if this screening strategy is cost-effective and warrants a change to the current approach of primary prevention of coronary heart disease in Australia.